FMR CORP 13D and 13G filings for 4D Molecular Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
FMR CORP | 1,140,174 3.547% |
-454,181 (-28.49%) |
Filing |
| 2021-02-08 10:15 am Purchase |
2021-02-05 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
FMR CORP | 1,594,355 7.382% |
1,594,355 (New Position) |
Filing |